Symbols

THRM

Gentherm·NASDAQ

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 2

Consensus Rating "Strong Buy"

Ample Liquidity

Significant Net Income Decline

High Cash/net Profit Ratio

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About THRM

Gentherm Incorporated

The global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry

Industry

Car parts

Established Date

Listing Date

06/10/1993

Exchange

NASDAQ Stock Exchange

Full-time Employees

14,174

Fiscal Year Ends

12-31

Website

www.gentherm.com

Security Type

Common stock

Office address

28875 Cabot Drive Novi MI 48377

Business

Introduction

Gentherm Incorporated was incorporated under the laws of the State of Michigan. Gentherm Incorporated is the world's leading provider of innovative thermal management and pneumatic comfort technologies. Its automotive products include climate controlled seats (CCS), climate controlled interiors (CCI), waist and massage comfort solutions, valve systems, and climate and comfort electronics. The Company is divided into two reporting segments: Automotive and Medical. The Automotive Reporting segment covers its global automotive business, including the design, development, manufacture and sale of automotive climate and comfort solutions (including climate controlled seats, climate controlled interiors, waist and massage comfort solutions, and climate and comfort electronics), valve systems and other automotive products. The medical reporting segment covers its patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories designed to meet the needs of high and low temperature therapy in intensive care, normal body temperature in surgery, and other warming/cooling therapies used in acute and chronic care departments and non-hospital institutions.

Company Financials

EPS

THRM has released its 2025 Q4 earnings. EPS was reported at 0.49, versus the expected 0.63, missing expectations. The chart below visualizes how THRM has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

THRM has released its 2025 Q4 earnings report, with revenue of 382.79M, reflecting a YoY change of 8.46%, and net profit of 2.99M, showing a YoY change of -80.50%. The Sankey diagram below clearly presents THRM's revenue sources and cost distribution.